Auguste A, Blanc-Durand F, Deloger M et al (2020) Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) beyond. Cells. 9:1496

PubMed  PubMed Central  Google Scholar 

Kolin DL, Quick CM, Dong F et al (2020) SMARCA4-deficient uterine sarcoma and undifferentiated endometrial carcinoma are distinct clinicopathologic entities. Am J Surg Pathol 44:263–270

PubMed  Google Scholar 

Kihara A, Amano Y, Matsubara D et al (2021) Infrequent loss of SMARCA4, SMARCA2, and SMARCB1 expression in uterine mesenchymal tumors. Hum Pathol 116:12–21

PubMed  Google Scholar 

Kolin DL, Dong F, Baltay M et al (2018) SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma. Mod Pathol 31:1442–1456

PubMed  Google Scholar 

Shinno Y, Yoshida A, Masuda K et al (2022) Efficacy of immune checkpoint inhibitors in SMARCA4-deficient thoracic tumor. Clin Lung Cancer 23:386–392

PubMed  Google Scholar 

Alessi JV, Ricciuti B, Spurr LF et al (2021) SMARCA4 and Other SWItch/sucrose nonfermentable family genomic alterations in NSCLC: clinicopathologic characteristics and outcomes to immune checkpoint inhibition. J Thorac Oncol 16:1176–1187

PubMed  Google Scholar 

Zhou H, Shen J, Liu J et al (2020) Efficacy of immune checkpoint inhibitors in SMARCA4-Mutant NSCLC. J Thorac Oncol 15:e133–e136

PubMed  Google Scholar 

Ramalingam P, Croce S, McCluggage WG (2017) Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology. Histopathology 70:359–366

PubMed  Google Scholar 

Kommoss FK, Tessier-Cloutier B, Witkowski L et al (2022) Cellular context determines DNA methylation profiles in SWI/SNF-deficient cancers of the gynecologic tract. J Pathol 257:140–145

PubMed  Google Scholar 

Kord A, Eppurath A, Drammeh H et al (2020) SMARCA4-deficient uterine sarcoma: A case report and a concise review. Case Rep Womens Health 27:e00231

PubMed  PubMed Central  Google Scholar 

Gao J, Fan R, Chen D et al (2023) Pathological characteristics and immune microenvironment of SMARCA4-deficient undifferentiated uterine sarcoma. Diagn Pathol 18:62

PubMed  PubMed Central  Google Scholar 

Baa AK, Rastogi S, Tripathy S et al (2021) Unfolding the rarity of SMARCA4 deficient uterine sarcoma (SDUS): A case report. Gynecol Oncol Rep 37:100788

PubMed  PubMed Central  Google Scholar 

Kurokawa M, Shimizuguchi T, Ito K et al (2021) Notable Response of SMARCA4-deficient undifferentiated uterine sarcoma to palliative radiation therapy. Adv Radiat Oncol 6:100728

PubMed  PubMed Central  Google Scholar 

Si M, Jia L, Song K et al (2017) Role of lymphadenectomy for uterine sarcoma: a meta-analysis. Int J Gynecol Cancer 27:109–116

PubMed  Google Scholar 

Lin YT, Li CF, Wu HC et al (2023) Case report: Heterogenous SMARCA4-deficient thoracic non-small cell lung carcinoma with various responses to nivolumab. Front Immunol 14:1131448

PubMed  PubMed Central  Google Scholar 

Lin Y, Yu B, Sun H et al (2023) Promising efficacy of immune checkpoint inhibitor plus chemotherapy for thoracic SMARCA4-deficient undifferentiated tumor. J Cancer Res Clin Oncol 149:8663–8671

PubMed  PubMed Central  Google Scholar 

Shi L, Lin L, Ding Y et al (2022) Case report: A rapid response to immunotherapy in a thoracic SMARCA4-deficient undifferentiated tumor with respiratory failure. Front Oncol 12:1020875

PubMed  PubMed Central  Google Scholar 

Blay JY, Chevret S, Le Cesne A et al (2023) Pembrolizumab in patients with rare and ultra-rare sarcomas (AcSé Pembrolizumab): analysis of a subgroup from a non-randomised, open-label, phase 2, basket trial. Lancet Oncol 24(8):892–902

PubMed  Google Scholar 

Chan-Penebre E, Armstrong K, Drew A et al (2017) Selective Killing of SMARCA2- and SMARCA4-deficient small cell carcinoma of the ovary, hypercalcemic type cells by inhibition of EZH2. Mol Cancer Ther. 16:850–60

PubMed  Google Scholar 

Kurashima K, Kashiwagi H, Shimomura I et al (2020) deficiency-associated heterochromatin induces intrinsic DNA replication stress and susceptibility to ATR inhibition in lung adenocarcinoma. NAR Cancer 2:zcaa005

PubMed  PubMed Central  Google Scholar